Literature DB >> 2013141

Expected gains in life expectancy from various coronary heart disease risk factor modifications.

J Tsevat1, M C Weinstein, L W Williams, A N Tosteson, L Goldman.   

Abstract

BACKGROUND: Despite much evidence that modifying risk factors for coronary heart disease can decrease morbidity and mortality, little is known about the impact of risk-factor modification on life expectancy. METHODS AND
RESULTS: We used the Coronary Heart Disease Policy Model, a state-transition computer simulation of the US population, to forecast potential gains in life expectancy from risk-factor modification for the cohort of Americans turning age 35 in 1990. Among 35-year-old men, we projected that the population-wide increase in life expectancy would be about 1.1 years from strict blood pressure control, 0.8 years from smoking cessation, 0.7 years from reduction of serum cholesterol to 200 mg/dl, and about 0.6 years from weight loss to ideal body weight. For women, reducing cholesterol to 200 mg/dl would have the greatest estimated impact-a gain of 0.8 years-whereas smoking cessation, blood pressure control, or weight loss would yield population-wide gains of 0.7, 0.4, and 0.4 years, respectively. Gains for 35-year-old individuals having a given risk factor are greater. We estimate that, on average, male smokers would gain 2.3 years from quitting smoking; males with hypertension would gain 1.1-5.3 years from reducing their diastolic blood pressure to 88 mm Hg; men with serum cholesterol levels exceeding 200 mg/dl would gain 0.5-4.2 years from lowering their serum cholesterol level to 200 mg/dl; and overweight men would gain an average of 0.7-1.7 years from achieving ideal body weight. Corresponding projected gains for at-risk women are 2.8 years from quitting smoking, 0.9-5.7 years from lowering blood pressure, 0.4-6.3 years from decreasing serum cholesterol, and 0.5-1.1 years from losing weight. Eliminating coronary heart disease mortality is estimated to extend the average life expectancy of a 35-year-old man by 3.1 years and a 35-year-old woman by 3.3 years.
CONCLUSIONS: Population-wide gains in life expectancy from single risk-factor modifications are modest, but gains to individuals at risk can be more substantial.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013141     DOI: 10.1161/01.cir.83.4.1194

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

1.  A scandal of inaction: how to help GPs implement evidence-based health promotion.

Authors:  B R McAvoy
Journal:  Br J Gen Pract       Date:  2000-03       Impact factor: 5.386

2.  Waiting for the great leap forward.

Authors:  A Logan; D Jewell
Journal:  Br J Gen Pract       Date:  2000-03       Impact factor: 5.386

3.  The expiry date of man: a synthesis of evolutionary biology and public health.

Authors:  L Bonneux; J J Barendregt; P J Van der Maas
Journal:  J Epidemiol Community Health       Date:  1998-10       Impact factor: 3.710

Review 4.  Cost per millimeter of mercury lowering is a measure of economic value for antihypertensive agents.

Authors:  R S Chen; P Lapuerta
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

5.  Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study.

Authors:  A Menotti; H Blackburn; D Kromhout; A Nissinen; H Adachi; M Lanti
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

6.  The cholesterol controversy.

Authors:  T Winder
Journal:  BMJ       Date:  1992-03-14

Review 7.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

8.  An expert system for simulation of coronary heart disease risk factor interventions.

Authors:  Z Zhou; E Ackerman; L Gatewood
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

9.  Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  P W Connelly; D R MacLean; L Horlick; B O'Connor; A Petrasovits; J A Little
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

10.  Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.

Authors:  J A Critchley; S Capewell
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.